Cite
HARVARD Citation
Marschner, N. et al. (2023). FOLFIRINOX or gemcitabine/nab‐paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision‐making in real‐world. International journal of cancer. 152 (3), pp. 458-469. [Online].